|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for PRKAR1A |
Basic gene info. | Gene symbol | PRKAR1A |
Gene name | protein kinase, cAMP-dependent, regulatory, type I, alpha | |
Synonyms | ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1 | |
Cytomap | UCSC genome browser: 17q24.2 | |
Genomic location | chr17 :66508109-66528910 | |
Type of gene | protein-coding | |
RefGenes | NM_001276289.1, NM_001276290.1,NM_001278433.1,NM_002734.4,NM_212471.2, NM_212472.2, | |
Ensembl id | ENSG00000108946 | |
Description | Carney complex type 1cAMP-dependent protein kinase regulatory subunit RIalphacAMP-dependent protein kinase type I-alpha regulatory chaincAMP-dependent protein kinase type I-alpha regulatory subunitprotein kinase A type 1a regulatory subunittissue-spe | |
Modification date | 20141219 | |
dbXrefs | MIM : 188830 | |
HGNC : HGNC | ||
Ensembl : ENSG00000108946 | ||
HPRD : 01786 | ||
Vega : OTTHUMG00000180128 | ||
Protein | UniProt: P10644 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_PRKAR1A | |
BioGPS: 5573 | ||
Gene Expression Atlas: ENSG00000108946 | ||
The Human Protein Atlas: ENSG00000108946 | ||
Pathway | NCI Pathway Interaction Database: PRKAR1A | |
KEGG: PRKAR1A | ||
REACTOME: PRKAR1A | ||
ConsensusPathDB | ||
Pathway Commons: PRKAR1A | ||
Metabolism | MetaCyc: PRKAR1A | |
HUMANCyc: PRKAR1A | ||
Regulation | Ensembl's Regulation: ENSG00000108946 | |
miRBase: chr17 :66,508,109-66,528,910 | ||
TargetScan: NM_001276289 | ||
cisRED: ENSG00000108946 | ||
Context | iHOP: PRKAR1A | |
cancer metabolism search in PubMed: PRKAR1A | ||
UCL Cancer Institute: PRKAR1A | ||
Assigned class in ccmGDB | A - This gene has a literature evidence and it belongs to cancer gene. | |
References showing role of PRKAR1A in cancer cell metabolism | 1. Robinson-White AJ, Bossis I, Hsiao H-P, Nesterova M, Leitner WW, et al. (2009) 8-Cl-adenosine inhibits proliferation and causes apoptosis in B-lymphocytes via protein kinase A-dependent and independent effects: implications for treatment of Carney complex-associated tumors. The Journal of Clinical Endocrinology & Metabolism 94: 4061-4069. go to article |
Top |
Phenotypic Information for PRKAR1A(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: PRKAR1A |
Familial Cancer Database: PRKAR1A |
* This gene is included in those cancer gene databases. |
. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM |
Others | |
OMIM | 101800; phenotype. 160980; phenotype. 188830; gene. 255960; phenotype. 610489; phenotype. |
Orphanet | 1359; Carney complex. 189439; Primary pigmented nodular adrenocortical disease. 280651; Acrodysostosis with multiple hormone resistance. 520; Acute promyelocytic leukemia. 615; Familial atrial myxoma. 950; Acrodysostosis. |
Disease | KEGG Disease: PRKAR1A |
MedGen: PRKAR1A (Human Medical Genetics with Condition) | |
ClinVar: PRKAR1A | |
Phenotype | MGI: PRKAR1A (International Mouse Phenotyping Consortium) |
PhenomicDB: PRKAR1A |
Mutations for PRKAR1A |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
There's no structural variation information in COSMIC data for this gene. |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows PRKAR1A related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
DA334350 | PRKAR1A | 3 | 285 | 17 | 66508618 | 66518922 | FAM65C | 286 | 595 | 20 | 49211470 | 49211779 | |
EF428111 | PRKAR1A | 1 | 182 | 17 | 66511536 | 66511717 | RARA | 181 | 332 | 17 | 38504566 | 38504717 | |
L03357 | PRKAR1A | 1 | 718 | 17 | 66511532 | 66522054 | RET | 717 | 1867 | 10 | 43612031 | 43622269 | |
BF965634 | PRKAR1A | 1 | 661 | 17 | 66508578 | 66521095 | RPS17L | 652 | 740 | 15 | 83207056 | 83207655 | |
EF428110 | PRKAR1A | 1 | 282 | 17 | 66511536 | 66518996 | RARA | 281 | 432 | 17 | 38504566 | 38504717 | |
AV751006 | TPP1 | 1 | 234 | 11 | 6635224 | 6635458 | PRKAR1A | 230 | 537 | 17 | 66527556 | 66527866 | |
BI550151 | NSL1 | 1 | 541 | 1 | 212964890 | 212977979 | PRKAR1A | 538 | 729 | 17 | 66526896 | 66527087 | |
AA508561 | PRKAR1A | 1 | 111 | 17 | 66527867 | 66527977 | PRKAR1A | 108 | 188 | 17 | 66527926 | 66528006 | |
CN478669 | PRKAR1A | 13 | 127 | 17 | 66528783 | 66528897 | PRKAR1A | 127 | 346 | 17 | 66528066 | 66528285 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample | 1 |   |   |   |   |   |   |   | 1 |   |   |   |   | 1 |   |   |   | |||
GAIN (# sample) | 1 |   |   |   |   |   |   |   | 1 |   |   |   |   | 1 |   |   |   | |||
LOSS (# sample) |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=36) | (# total SNVs=9) |
(# total SNVs=5) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr17:66518949-66518949 | p.S77* | 3 |
chr17:66522027-66522027 | p.R228* | 3 |
chr17:66526077-66526095 | p.Q304fs*21 | 2 |
chr17:66526060-66526060 | p.? | 2 |
chr17:66524000-66524000 | p.R243Q | 2 |
chr17:66526061-66526074 | p.? | 1 |
chr17:66519878-66519878 | p.D121Y | 1 |
chr17:66526498-66526498 | p.R352* | 1 |
chr17:66511555-66511561 | p.S5fs*122 | 1 |
chr17:66521903-66521903 | p.V186V | 1 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 1 | 3 |   | 6 |   |   | 3 |   | 2 |   |   | 2 | 1 |   |   |   |   | 6 |   | 4 |
# mutation | 1 | 3 |   | 8 |   |   | 3 |   | 2 |   |   | 2 | 1 |   |   |   |   | 6 |   | 4 |
nonsynonymous SNV | 1 | 1 |   | 6 |   |   | 2 |   | 2 |   |   | 1 | 1 |   |   |   |   | 4 |   | 3 |
synonymous SNV |   | 2 |   | 2 |   |   | 1 |   |   |   |   | 1 |   |   |   |   |   | 2 |   | 1 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr17:66524033 | p.T6T,PRKAR1A | 1 |
chr17:66511558 | p.T192T,PRKAR1A | 1 |
chr17:66519048 | p.A7A,PRKAR1A | 1 |
chr17:66525030 | p.K222R,PRKAR1A | 1 |
chr17:66511561 | p.R13H,PRKAR1A | 1 |
chr17:66519878 | p.G225D,PRKAR1A | 1 |
chr17:66525084 | p.L15F,PRKAR1A | 1 |
chr17:66511578 | p.L250R,PRKAR1A | 1 |
chr17:66519945 | p.Y21Y,PRKAR1A | 1 |
chr17:66526076 | p.V253A,PRKAR1A | 1 |
Other DBs for Point Mutations |
Copy Number for PRKAR1A in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for PRKAR1A |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
AMZ2,APPBP2,BPTF,SMG8,CLCN3,CLTC,DCAF7, DHX40,DYNLL2,GNA13,HELZ,INTS2,LOC651250,MED13, NOL11,PRKAR1A,PSMD12,STXBP4,TLK2,TRIM37,VEZF1 | ANKRD13C,BNIP2,C6orf120,CDC73,EPS15,EXOC5,FAM160B1, HCFC2,LUZP6,NCKAP1,OSBPL8,BLOC1S6,PRKAR1A,SERINC3, SHOC2,SMAD2,TBC1D23,TMED5,TMX3,TOR1AIP1,VAMP7 | ||||
A4GNT,AMZ2,APPBP2,BCAR4,BPTF,CLTC,COX8C, CPS1,DZIP1L,GABRP,HELZ,LIPC,LOC100128239,LOC651250, PRKAR1A,RPS6KB1,SLC16A2,TANC2,TRIM61,USP32,YPEL2 | ARMCX3,CEP170,EHBP1,IFT81,LBR,LRRK2,MTMR9, SLC9B2,NOVA1,NPAS3,NUCKS1,PBX3,PPFIBP1,PRKAR1A, PSIP1,QKI,RAB11FIP2,RBMS1,RIMKLB,SLC39A6,TCF4 |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for PRKAR1A |
Cross-referenced pharmacological DB IDs from Uniprot |
DB Category | DB Name | DB's ID and Url link |
Organism-specific databases | PharmGKB | PA33754; -. |
Organism-specific databases | CTD | 5573; -. |
Drug-Gene Interaction Network |
* Gene Centered Interaction Network. |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB01790 | protein kinase, cAMP-dependent, regulatory, type I, alpha | experimental | Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate | ||
DB02315 | protein kinase, cAMP-dependent, regulatory, type I, alpha | experimental | Cyclic Guanosine Monophosphate | ||
DB02527 | protein kinase, cAMP-dependent, regulatory, type I, alpha | experimental | Cyclic Adenosine Monophosphate | ||
DB00125 | protein kinase, cAMP-dependent, regulatory, type I, alpha | approved; nutraceutical | L-Arginine | ||
DB00155 | protein kinase, cAMP-dependent, regulatory, type I, alpha | approved; nutraceutical | L-Citrulline | ||
DB00435 | protein kinase, cAMP-dependent, regulatory, type I, alpha | approved | Nitric Oxide | ||
DB00988 | protein kinase, cAMP-dependent, regulatory, type I, alpha | approved | Dopamine | ||
DB00171 | protein kinase, cAMP-dependent, regulatory, type I, alpha | approved; nutraceutical | Adenosine triphosphate | ||
DB00770 | protein kinase, cAMP-dependent, regulatory, type I, alpha | approved; investigational | Alprostadil | ||
DB00668 | protein kinase, cAMP-dependent, regulatory, type I, alpha | approved | Epinephrine | ||
DB00131 | protein kinase, cAMP-dependent, regulatory, type I, alpha | approved; nutraceutical | Adenosine monophosphate | ||
DB00396 | protein kinase, cAMP-dependent, regulatory, type I, alpha | approved | Progesterone |
Top |
Cross referenced IDs for PRKAR1A |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |